AAPS 2023: interviews from the floor with Dominic Warrino

During the American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 2023 conference, Bioanalysis Zone caught up with industry experts across numerous disciplines to discuss their involvement with AAPS, the current trends in bioanalysis and their wants and needs for the future. In this interview, we spoke to Senior Director of Scientific Services Dominic Warrino about how the cell and gene therapy space has evolved during his career in immunology and some of the new concepts helping to guide the next generation of therapeutics.

Speaker

Dominic Warrino, PhD
Senior Director of Scientific Services
KCAS Bioanalytical and Biomarker Services (KS, USA)

Dominic Warrino, PhD, is a Senior Director of Scientific Services. His role is to serve as scientific and technical advisor for both clients and internal teams for the development, validation and application of bioanalytical, immunogenicity and biomarker methods for large molecule therapeutics. Dominic joined the company in 2013 and brought with him expertise in a full range of bioanalytical techniques including ECL, ELISA, RIA, flow cytometry, ELISpot, cell-based assays and Luminex. He has 20 years of experience developing and validating immunological assays for biotechnology and pharmaceutical companies. He most recently spent several years in the Biopharma Services department at Viracor-IBT (formally IBT; MO, USA), and previously also worked for Cytogen (formally Cellcor; NJ, USA), Eligix (MA, USA) and Streck Laboratories (NE, USA) developing novel compounds for the treatment of various cancers. Dominic has worked on over 100 large molecule compounds developing and validating PK, PD, ADA and biomarker assays in support of pre-clinical to phase IV testing.

Interested in learning more about PharmSci 360? View our conference report here.

About AAPS

American Association of Pharmaceutical Scientists (AAPS) is a non-profit association of more than 7000 scientists and professionals employed in academia, industry, regulatory and other research related to the pharmaceutical sciences worldwide. Its mission is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health, which members pursue through four peer-reviewed journals and a variety of events in person and online.